Metformin loaded non-ionic surfactant vesicles: Optimization of formulation, effect of process variables and characterization

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Sankhyan, Anchal ^a   Pawar, Pravin K ^a  

^a CHITKARA UNIVERSITY   (India)

Author keywords

Anti diabetic; Dicetyl phosphate; Metformin; Niosomes; Sustained release

Indexed keywords

CHOLESTEROL; DICETYL PHOSPHATE; METFORMIN; NIOSOME; SURFACTANT;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HYDRATION; IN VITRO STUDY; KINETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84872722251     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-7     Document Type: Article

References (38)

1. Furness G, OnDrugDelivery [ http://www.ondrugdelivery.com/publications/ Oral-Drug-Delivery-07.pdf ]
2. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. Krishnaiah YSR, J Bioequiv Availab 2010 2 28 36 10.4172/jbb.1000027
3. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. Luo YF, Chen DW, Ren LX, Zhao XL, Qin J, J Control Release 2006 114 53 59 10.1016/j.jconrel.2006.05.010 16828192
4. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. Schnürch AB, Guggib D, Pinter Y, J Control Release 2004 94 177 186 10.1016/j.jconrel.2003.10. 005 14684281 (Pubitemid 37542387)
5. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Fatouros DG, Mullertz A, Expert Opin Drug Metab Toxicol 2008 4 65 76 10.1517/17425255.4.1.65 18370859 (Pubitemid 351234101)
6. Enhanced oral bioavailability of a poorly water soluble drug PNU91325 by supersaturatable formulations. Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q, Drug Dev Ind Pharm 2004 30 221 229 10.1081/DDC-120028718 15089057 (Pubitemid 38420267)
7. Improved oralbioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Vyas TK, Shahiwala A, Amiji MM, Int J Pharm 2008 347 93 101 10.1016/j.ijpharm.2007.06.016 17651927 (Pubitemid 350180312)
8. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug. Nassara T, Roma A, Nyskab A, Benita S, J Control Release 2009 133 77 84 10.1016/j.jconrel.2008.08. 021 18822327
9. Recent technological advances in oral drug delivery-a review. Sastry SV, Nyshadham JR, Fix JA, Pharm Sci Technol To 2000 3 138 145 10.1016/S1461-5347(00) 00247-9 (Pubitemid 30195827)
10. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. Sant VP, Smith D, Lerouxa JC, J Control Release 2004 97 301 312 10.1016/j.jconrel.2004.03.026 15196757 (Pubitemid 38759487)
11. Epidemiology of Diabetes and Diabetes-Related Complications. Deshpande AD, Hayes MH, Schootman M, Phys Ther 2008 88 1254 1264 10.2522/ptj.20080020 18801858
12. The potential of metformin for diabetes prevention. Slama G, Diabetes Metab 2003 29 104 111
13. The Relationship between the Drug Concentration Profiles in Plasma and the Drug Doses in the Colon. Tajiri S, Kanamaru T, Yoshida K, Hosoi Y, Konno T, Yada S, Nakagami H, Chem Pharm Bull 2010 58 1295 1300 10.1248/cpb.58.1295 20930393
14. Formulation and Optimization of Sustained release matrix tablet of Metformin HCl 500mg using response surface methodology. Mandal U, Gowda V, Ghosh A, Selvan S, Solomon S, Pal TK, Yakugaku Zasshi 2007 127 1281 1290 10.1248/yakushi.127.1281 17666882 (Pubitemid 47204009)
15. Lactic Acidosis Rates in Type 2 Diabetes. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P, Diabetes Care 1998 21 1659 1663 10.2337/diacare.21.10.1659 9773726 (Pubitemid 28449803)
16. Formulation and Evaluation of Sustained-Release Tablets of Metformin Hydrochloride Using Hydrophilic Synthetic and Hydrophobic Natural Polymers. Indian. Wadher KJ, Kakde RB, Umekar MJ, J Pharm Sci 2011 73 208 215
17. The Weinberg Group Inc.: FDA: [ http://www.fda.gov/ohrms/dockets/dailys/ 04/may04/050404/04p-0208-cp00001-03-Attachment-02-vol1.pdf?utm-campaign= Google2&utm-source=fdaSearch&utm-medium=website&utm-term= metformin-glipizide%20tablets%20for%20oral%20suspension&utm-content=1 ]
18. Lachman Consultant Services Inc.: FDA, [ http://www.fda.gov/ohrms/ dockets/dailys/03/Nov03/112193/03p-0534-cp00001-03-attachment-2-vol1.pdf? utm-campaign=Google2&utm-source=fdaSearch&utm-medium= website&utm-term=metformin-glyburide%20oral%20solution&utm-content=1 ]
19. Boehringer Ingelheim: FDA, [ http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/index.cfm?fuseaction=Search.DrugDetails ]
20. Enhanced Oral Bioavailability of Griseofulvin via Niosomes. Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N, AAPS PharmSciTech 2009 10 1186 1192 10.1208/s12249-009-9325-z 19856107
21. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies. Sihorkar V, Vyas SP, Pharmazie 2000 55 107 13 10723768 (Pubitemid 30243261)
22. Release of metformin hydrochloride from ispaghula sodium alginate beads adhered cock intestinal mucosa. Patel FM, Patel AN, Rathore KS, Int J Curr Pharmaceut Res 2011 3 52 55
23. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Kumar GP, Rajeshwarrao P, Acta Pharmaceutica Sinica B 2011 1 208 219 10.1016/j.apsb.2011.09.002
24. Proniosomes: A Novel Drug Carrier Preparation. Chengjiu H, David Rhodes G, Int J Pharm 1999 185 23 35 10.1016/S0378-5173(99)00122-2 10425362 (Pubitemid 29333093)
25. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus. Abdel-Mottaleb MMA, Lamprecht A, Drug Dev Ind Pharm 2011 37 178 184 10.3109/03639045.2010.502534 21073322
26. Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes. Junyaprasert VB, Teeranachaideekul V, Supaperm T, AAPS PharmSciTech 2008 9 851 859 10.1208/s12249-008-9121-1 18636334
27. Niosomal Delivery of Isoniazid-Development and Characterization. Singh G, Dwivedi H, Saraf SK, Saraf SA, Trop J Pharm Res 2011 10 203 210
28. Niosomes from α, ω-trioxyethylene-bis(sodium2-dodecyloxy- propylenesulfonate): Preparation and characterization. Muzzalupo R, Tavano L, Trombino S, Cassano R, Picci N, Mesa CL, Colloids Surf B Biointerfaces 2008 64 200 207 10.1016/j.colsurfb.2008.01.026 18378125
29. Preparation and evaluation of niosomes containing Aceclofenac. Srinivas S, Kumar YA, Hemanth A, Anitha M, Dig J Nanomater Bios 2010 5 249 254
30. Studies in topical application of niosomally entrapped nimuslide. Shahiwala A, Misra A, J Pharm Pharm Sci 2002 5 220 225 12553889 (Pubitemid 37211713)
31. Influence of a Niosomal Formulation on the Oral Bioavailability of Acyclovir in Rabbits. Attia IA, El-Gizawy SA, Fouda MA, Donia AM, AAPS PharmSciTech 2007 8 1 E7
32. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Hao YM, Li K, Int J Pharm 2011 403 245 253 10.1016/j.ijpharm.2010.10.027 20971171
33. Niosomes as carriers for tretinoin. I. Preparation and properties. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM, Int J Pharm 2002 234 237 248 10.1016/S0378-5173(01)00971-1 11839454 (Pubitemid 34142628)
34. Niosomal delivery of 5-Fluorouracil. Namdeo A, Jain NK, J Microencapsul 1999 16 731 740 10.1080/026520499288672 10575625 (Pubitemid 29478952)
35. Formulation and Optimization of Zidovudine Niosomes. Kandasamy R, Veintramuthu S, AAPS PharmSciTech 2010 11 1119 1127 10.1208/s12249-010-9480-2 20635228
36. A Langmuir film approach to elucidating interactions in lipid membranes: 1,2-dipalmitoyl-sn-glycero-3- phosphoethanolamine/ cholesterol/ metal cation systems. Korchowiec B, Paluch M, Corvis Y, Rogalska E, Chem Phys Lipids 2006 144 127 136 10.1016/j.chemphyslip.2006.08.005 17027949 (Pubitemid 44737471)
37. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Guinedi AS, Mortada ND, Mansour S, Hathout RM, Int J Pharm 2005 306 71 82 10.1016/j.ijpharm.2005.09.023 16263229 (Pubitemid 41643141)
38. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Bayindir ZS, Yuksel N, J Pharm Sci 2010 99 2049 2060 19780133